• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Search
Skip to main content
Advertisement

Schering-Plough

  1. Business
  2. Pharmaceuticals
  3. Schering-Plough
Jim Robinson on how we need to adjust to the future of work Thrive Global20:36Pharma
Madrigal pharmaceuticals appoints Ronald filippo as chief information officer BioSpace12:16Biotechnology Nasdaq Pharma

Latest News

In the last 7 days
Petauri™ Elects William Fleming and James Robinson to Its Board of Directors PR Newswire (Press Release)08:06 6-Dec-23
In the last month
Jim Robinson On How We Need To Adjust To The Future Of Work Thrive Global20:36 21-Nov-23
Madrigal Pharmaceuticals Appoints Ronald Filippo as Chief Information Officer BioSpace12:16 21-Nov-23
view more headlines
6 Dec 08:06

Schering-Plough News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Schering-Plough news, covering the latest share price, company announcements, product trials, pharmaceuticals news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
Read more

Pharmaceuticals Top Stories

US agency approves cure for Sickle Cell Disease Leadership, Nigeria16:17CRISPR/Gene Editing FDA Business (US)
U.S. FDA approves two gene therapies for sickle cell disease CTV News Edmonton12:11CRISPR/Gene Editing FDA Business (US)
US approves CRISPR gene-editing to treat sickle cell disease Deutsche Welle14:55CRISPR/Gene Editing FDA
FDA approves two gene therapies for sickle cell, bringing hope to thousands with the disease WHDH-TV, Massachusetts14:11CRISPR/Gene Editing FDA
AbbVie buys Cerevel Therapeutics for $8.7B, Bolstering neuroscience portfolio Investopedia15:29AbbVie Biotech Cerevel Therapeutics
AbbVie to acquire Cerevel Therapeutics for $8.7 Billion European Pharmaceutical Manufacturer05:48AbbVie Biotech Cerevel Therapeutics
New sickle cell Drug awaiting FDA approval met with mixed emotions Black Enterprise10:03CRISPR/Gene Editing FDA
FDA approves two sickle cell therapies, including the first CRISPR medicine The Guam Daily Post09:15CRISPR/Gene Editing FDA
Merck-Eisai uterine cancer drug combination fails first-line treatment study Proactive Investors (US)09:37Keytruda Merck & Co Eisai
MSD’s Keytruda and Eisai’s Lenvima fail in Phase III uterine cancer trial Pharmaceutical Technology09:34Keytruda Merck & Co Eisai

Business Top Stories

The S&P 500 just had 1 of its best months in history. Here's what the stock market usually does next The Motley Fool09:54Dow Jones S&P 500 Nasdaq
Be careful what you wish for: This event may signal the start of the 2024 bear market The Motley Fool05:09Dow Jones S&P 500 Nasdaq
Elon Musk reactivates Alex Jones' X accounts after a five-year ban CNBC09:47X (Twitter) Elon Musk Alex Jones
Elon Musk’s Grok Twitter AI is actually ‘Woke,’ hilarity ensues Forbes09:27X (Twitter) Elon Musk Alex Jones
Elon Musk says Ilya Sutskever—the OpenAI chief scientist who helped fire Sam Altman then… Yahoo! US07:59Sam Altman OpenAI AI
OpenAI’s Sam Altman was said to be psychologically abusive, Washington Post reports The Messenger11:16Sam Altman OpenAI AI
EU sets global precedent with comprehensive AI regulation deal ReadWriteWeb16:50AI IT ChatGPT
Europe seals world's first set of rules regulating artificial intelligence Fox News12:58AI IT ChatGPT
UPenn President Liz Magill has resigned, but antisemitism remains a problem on college campuses CNN Money06:19Antisemitism Business (US) Politics
The 4 key events that led to UPenn President Liz Magill’s resignation CNN (Video)10:51Antisemitism Business (US) Politics
Publication filters

Headline Density

Notifications

  • Unsubscribe from Breaking News
    Sorry, no headlines or news topics were found. Please try different keywords.